相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
Asier Gonzalez et al.
CELL METABOLISM (2020)
Mechanisms and regulation of cholesterol homeostasis
Jie Luo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Brothers in Arms: ABCA1-and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment
Sanne J. C. M. Frambach et al.
PHARMACOLOGICAL REVIEWS (2020)
Lipid efflux mechanisms, relation to disease and potential therapeutic aspects
David Castano et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease
So Ra Kim et al.
NATURE COMMUNICATIONS (2020)
LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis Insight From Mouse Models
Lidia Cedo et al.
CIRCULATION RESEARCH (2020)
The SGLT2 inhibitor canagliflozin suppresses lipid synthesis and interleukin-1 beta in ApoE deficient mice
Emily A. Day et al.
BIOCHEMICAL JOURNAL (2020)
Genetic variability in the absorption of dietary sterols affects the risk of coronary artery disease
Anna Helgadottir et al.
EUROPEAN HEART JOURNAL (2020)
The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway
Xuping Yang et al.
ADIPOCYTE (2020)
Metformin and AMP Kinase Activation Increase Expression of the Sterol Transporters ABCG5/8 (ATP-Binding Cassette Transporter G5/G8) With Potential Antiatherogenic Consequences
Matthew M. Molusky et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells
Chenke Xu et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Liver X receptors in lipid signalling and membrane homeostasis
Bo Wang et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Canagliflozin inhibits interleukin-1 beta-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms
Sarah J. Mancini et al.
SCIENTIFIC REPORTS (2018)
Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition
Debapriya Basu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
Narjes Nasiri-Ansari et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
Kenneth W. Mahaffey et al.
CIRCULATION (2018)
Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages
Cong-hui Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Streptozotocin-Treated High Fat Fed Mice: A New Type 2 Diabetes Model Used to Study Canagliflozin-Induced Alterations in Lipids and Lipoproteins
Tian Yu et al.
HORMONE AND METABOLIC RESEARCH (2017)
AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE-/- mice
Ang Ma et al.
JOURNAL OF LIPID RESEARCH (2017)
Effects of canagliflozin on weight loss in highfat diet-induced obese mice
Wenjun Ji et al.
PLOS ONE (2017)
Autophagy gene ATG7 regulates ultraviolet radiation-induced inflammation and skin tumorigenesis
Lei Qiang et al.
AUTOPHAGY (2017)
Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport
Helen H. Wang et al.
ANNALS OF HEPATOLOGY (2017)
AMPK signalling in health and disease
David Carling
CURRENT OPINION IN CELL BIOLOGY (2017)
The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels
Simon A. Hawley et al.
DIABETES (2016)
AMPK activates LXRα and ABCA1 expression in human macrophages
Marina Kemmerer et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
AMPK Activation of Muscle Autophagy Prevents Fasting-Induced Hypoglycemia and Myopathy during Aging
Adam L. Bujak et al.
CELL METABOLISM (2015)
Clinical Pharmacokinetic, Pharmacodynamic, and Drug-Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor
Damayanthi Devineni et al.
CLINICAL PHARMACOKINETICS (2015)
Salicylate improves macrophage cholesterol homeostasis via activation of Ampk
Morgan D. Fullerton et al.
JOURNAL OF LIPID RESEARCH (2015)
MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels
Leigh Goedeke et al.
NATURE MEDICINE (2015)
Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development
Jimmy F. P. Berbee et al.
NATURE COMMUNICATIONS (2015)
Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study
Kaj Stenlof et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk
Fleur Lien et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
K. Stenlof et al.
DIABETES OBESITY & METABOLISM (2013)
Bile Acid Metabolism and Signaling
John Y. L. Chiang
COMPREHENSIVE PHYSIOLOGY (2013)
Effect of Macrophage Overexpression of Murine Liver X Receptor-α (LXR-α) on Atherosclerosis in LDL-Receptor Deficient Mice
Daniel Teupser et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited
Federica Basso et al.
JOURNAL OF LIPID RESEARCH (2007)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr--/- mice
KR Wilund et al.
JOURNAL OF LIPID RESEARCH (2004)
Liver X receptor signaling pathways in cardiovascular disease
P Tontonoz et al.
MOLECULAR ENDOCRINOLOGY (2003)
分享论文
